(FC) Bioquímica y Genética
Departamento académico
Stony Brook University
Stony Brook, Estados UnidosStony Brook University-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173Amice
Nucleic Acids Research, Vol. 50, Núm. 14, pp. 8093-8106
2019
-
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)
Nature Immunology
-
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Blood, Vol. 133, Núm. 22, pp. 2401-2412
-
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
Nature Immunology
2012
-
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions
Blood, Vol. 120, Núm. 24, pp. 4802-4811